gene editing biotech

Breakthroughs in regenerative medicine applications are redefining the therapeutic landscape across multiple high-burden disease categories in the United States. From cell-based therapies to bioengineered tissues, the field is advancing beyond experimental promise toward clinically validated interventions with regulatory and commercial traction. As academic innovation converges with venture-backed biotechnology platforms, regenerative medicine is increasingly positioned within … Read more